[PrEP 4 All Collaboration] The decision by Health and Human Services (HHS) to sue Gilead for patent infringement on Truvada and Descovy PrEP is a critical step to provide access to effective HIV prevention to everyone who needs it. Gilead’s conduct is unconscionable and has had disastrous consequences. In the suit, HHS spells this out plainly: “Gilead’s conduct was malicious, wanton, deliberate, consciously wrongful, flagrant, and in bad faith.”